Integra Holdings
Jerusalem, Jerusalem Districtintegra-holdings.com
Overview
Integra Holdings is a healthcare investment company with an exclusive first right to examine the innovations and intellectual property emerging from the world-renowned Hebrew University of Jerusalem. With a focus on biopharmaceuticals and medical diagnostics and devices, Integra employs multidisciplinary teams of experts who work alongside inventors and take a hands-on approach to achieve commercial success. Integra provides know-how and support to its portfolio companies from inception to commercialization, while leveraging its extensive industry network cultivated over decades of experience.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nectin Therapeutics | May 2024 | Series A | Co-investor |
| SpliSense | Apr 2024 | Strategic | Co-investor |
| Nectin Therapeutics | May 2023 | VC Round | Co-investor |
| Nectin Therapeutics | Nov 2022 | Series A Extension | - |
| SpliSense | May 2021 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.